Drugs Made In America Acquisition Corp. Units closed at $10.99 on Sep 21, up 1.85%, 2.9% below its highest close since Jan 28. Volume of 100 shares was 0.04× its 20-day average (below normal).
Short interest was 1 shares at the Sep 15 settlement (1.0 days to cover).
No reported quarters with price history yet.
Percentile among 164 companies (100 = best)
Industry medians: 6-month return +2.1%, revenue growth −2.0%, net margin −34.2%, P/E 43.1×.
| Company | Price | Today | 6M | Rev. growth | Net margin | P/E | Mkt cap | |
|---|---|---|---|---|---|---|---|---|
| DMAAUDrugs Made In America Acquisition Corp. Units | $10.99 | +1.85% | — | — | — | — | $224.2M | |
| ALDFUAldel Financial II Inc. Units | $10.94 | +0.37% | — | −10.8% | 94.8% | 19.6 | $225.8M | Compare |
| RDAGURepublic Digital Acquisition Company Unit | $10.53 | +0.29% | — | — | — | — | $231.7M | Compare |
| ATIIUArchimedes Tech SPAC Partners II Co. Unit | $11.30 | 0.00% | — | — | — | — | $234.6M | Compare |
| TVACUTexas Ventures Acquisition III Corp Unit | $10.65 | −1.11% | — | — | −12.6% | — | $213.0M | Compare |
| HAVAUHarvard Ave Acquisition Corporation Unit | $10.30 | +0.68% | — | — | — | — | $188.9M | Compare |
| GPATUGP-Act III Acquisition Corp. Units | $10.99 | +1.10% | — | — | — | — | $274.8M | Compare |
| NTWOUNewbury Street II Acquisition Corp Unit | $11.40 | −0.87% | — | — | — | — | $177.8M | Compare |
| NPACUNew Providence Acquisition Corp. III Units | $10.51 | +0.10% | — | — | — | 34.5 | $283.3M | Compare |
No recent articles focused on Drugs Made In America Acquisition Corp. Units.
Drugs Made In America Acquisition Corp is a blank check company.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology